نتائج البحث

Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients

• Authors : Merck Sharp & Dohme LLC; Vadim Pokrovsky, Professor

• Source: Efficacy and Safety of an Initial Regimen Raltegravir (RAL) + Lamivudine/Abacavir Fixed-Dose Combination (3TC/ABC FDC) for 48 Weeks in ART- naïve, HIV/TB Co-Infected

تفاصيل العنوان

Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected Individuals (AVERTAS)

• Authors : Thomas Benfield, MD, DMsc, professor

• Source: Changes in Weight and Body Composition After Switch to Dolutegravir/Lamivudine Compared to Continued Dolutegravir/Abacavir/Lamivudine for Virologically Suppressed HIV

تفاصيل العنوان

Mitoxantrone and abacavir: An ALK protein-targeted in silico proposal for the treatment of non-small cell lung cancer.

• Authors : Faya Castillo, Juan Enrique¹ (AUTHOR) ; Zapata Dongo, Richard Junior¹ (AUTHOR); Wong Chero, Paolo Alberto² (AUTHOR)

Subjects: *NON-small-cell lung carcinoma; *ABACAVIR; *MITOXANTRONE

• Source: PLoS ONE. 2/6/2024, Vol. 19 Issue 2, p1-18. 18p.

تفاصيل العنوان

Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV

• Authors : Jaschinski, N; Greenberg, L; Neesgaard, B

Subjects: Medicin och hälsovetenskap

• Source: AIDS (London, England). 37(3):467-475

تفاصيل العنوان

Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosus (PENCIL)

• Source: Randomized Pilot Trial to Evaluate the Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosus (PENCIL)

تفاصيل العنوان

SYNTHESIS, MOLECULAR DOCKING, IN-SILICO ADMET SCREENING, STRUCTURAL SAFETY EVALUATION OF ABACAVIR SULFATE AND ITS NOVEL MODIFIED SUBSTANCE.

• Authors : Ananda, Mohit¹; C., Chandan¹; Ghosh, Abhishek¹

• Source: Rasayan Journal of Chemistry. Jul-Sep2023, Vol. 16 Issue 3, p1137-1148. 12p.

تفاصيل العنوان

Abacavir causes leukocyte/platelet crosstalk by activating neutrophil P2X7 receptors thus releasing soluble lectin‐like oxidized low‐density lipoprotein receptor‐1.

• Authors : Blanch‐Ruíz, Maria Amparo¹ (AUTHOR); Sánchez‐López, Ainhoa¹ (AUTHOR); Ríos‐Navarro, César¹ (AUTHOR)

• Source: British Journal of Pharmacology. Jun2023, Vol. 180 Issue 11, p1516-1532. 17p. 7 Graphs.

تفاصيل العنوان

AOP-Based Transformation of Abacavir in Different Environments: Evolution Profile of Descyclopropyl-Abacavir and In Silico Toxicity Assessment of the Main Transformation Products.

• Authors : Evgenidou, Eleni^1,2 (AUTHOR); Vasilopoulou, Konstantina¹ (AUTHOR); Koronaiou, Lelouda-Athanasia^1,2 (AUTHOR)

Subjects: *ABACAVIR; *ANTIVIRAL agents; *LEACHATE

• Source: Molecules. Feb2023, Vol. 28 Issue 4, p1866. 15p.

تفاصيل العنوان

Comparison of Chemical and Electrochemical Approaches to Abacavir Oxidative Stability Testing.

• Authors : Pražáková, Lucie¹ (AUTHOR); Fischer, Jan¹ (AUTHOR) ; Taylor, Andrew² (AUTHOR)

• Source: Sensors (14248220). Mar2023, Vol. 23 Issue 5, p2776. 12p.

تفاصيل العنوان

Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1.

• Authors : Chandasana, Hardik¹ (AUTHOR) ; van Dijkman, Sven C.² (AUTHOR); Mehta, Rashmi³ (AUTHOR)

• Source: Infectious Diseases & Therapy. Aug2024, Vol. 13 Issue 8, p1877-1891. 15p.

تفاصيل العنوان